Evidence map›Paper›PMID 41311933›Full record

ArticleJACS Au2025

Impact of Tryptophan Positional Isomerism on Physicochemical and Biological Properties: A Case Study Using Gramicidin A Analogs.

Takahiro Migita, Hiroaki Itoh, Hiroshi Hamamoto, Masayuki Inoue

Abstract read
In one paragraph

Article in JACS Au, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Takahiro MigitaGraduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
Hiroaki ItohGraduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.ORCID https://orcid.org/0000-0002-1329-6109
Hiroshi HamamotoFaculty of Medicine, Yamagata University, 2-2-2 Iida-Nishi, Yamagata, Yamagata 990-9585, Japan.ORCID https://orcid.org/0000-0001-9315-7442
Masayuki InoueGraduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.ORCID https://orcid.org/0000-0003-3274-551X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tryptophan (Trp) displays unique physicochemical properties due to its C3-substituted indole ring, containing a hydrophobic benzene ring and a hydrophilic N-H bond. Herein, we synthetically incorporated five Trp positional isomers with C2/4/5/6/7-substituted indoles in place of the Trp of residue 11 in gramicidin A, a 15-mer linear peptidic natural product. Gramicidin A conducts monovalent cations across the cell membrane and exhibits potent toxicity against both bacterial and mammalian cells. Our functional evaluation of the five analogs revealed that positional isomerism controlled the overall hydrophobicity and biological activities for the first time. Most importantly, we found that the hydrophobicity of the analogs correlated with the potency of mammalian cytotoxicity but not with the strength of the antibacterial activity, indicating that antibacterial and mammalian toxicities can be separated only by tuning the hydrophobicity. In addition, we designed and synthesized a triply mutated analog, in which the original valine, leucine, and Trp were replaced with less hydrophobic threonine, valine, and a C5-isomer, respectively. While the original antibacterial activity was maintained, the mammalian toxicity of the analog was more than 20-fold weaker. Consequently, these new findings offer a novel molecular editing approach to optimize the physicochemical and biological properties of Trp-containing bioactive peptides and proteins.

Indexed as

antibacterial activityhydrophobicitymammalian cytotoxicitymolecular editingpositional isomerssolid-phase synthesisstructure-activity relationshipstryptophan

Identifiers

PMID41311933
PMCPMC12648344

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.